MultiPlan Co. (NYSE:MPLN – Get Free Report) shares gapped down before the market opened on Tuesday after Citigroup lowered their price target on the stock from $17.20 to $10.00. The stock had previously closed at $8.95, but opened at $8.71. Citigroup currently has a neutral rating on the stock. MultiPlan shares last traded at $8.08, with a volume of 29,321 shares trading hands.
Separately, Piper Sandler restated a “neutral” rating and issued a $1.00 price target (down previously from $2.00) on shares of MultiPlan in a research note on Wednesday, August 7th.
Get Our Latest Research Report on MultiPlan
Insider Activity at MultiPlan
Hedge Funds Weigh In On MultiPlan
A number of large investors have recently made changes to their positions in MPLN. Charles Schwab Investment Management Inc. raised its stake in shares of MultiPlan by 6.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,522,486 shares of the company’s stock worth $12,272,000 after purchasing an additional 482,944 shares in the last quarter. Empowered Funds LLC boosted its position in MultiPlan by 98.8% during the first quarter. Empowered Funds LLC now owns 1,550,620 shares of the company’s stock worth $1,258,000 after purchasing an additional 770,826 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in MultiPlan by 68.8% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 45,653 shares of the company’s stock valued at $37,000 after purchasing an additional 18,603 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of MultiPlan by 19.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 407,105 shares of the company’s stock valued at $331,000 after purchasing an additional 66,172 shares during the period. Finally, Fore Capital LLC acquired a new stake in shares of MultiPlan in the second quarter worth $37,000. Institutional investors and hedge funds own 87.15% of the company’s stock.
MultiPlan Trading Down 7.1 %
The company’s fifty day moving average is $0.30 and its 200-day moving average is $0.50. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 7.48. The firm has a market capitalization of $5.36 billion, a P/E ratio of -8.24 and a beta of 0.52.
MultiPlan (NYSE:MPLN – Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.01. The business had revenue of $233.48 million during the quarter, compared to analysts’ expectations of $253.59 million. MultiPlan had a negative return on equity of 8.90% and a negative net margin of 122.73%. During the same quarter in the previous year, the firm earned ($0.06) EPS. As a group, sell-side analysts anticipate that MultiPlan Co. will post -0.18 earnings per share for the current fiscal year.
MultiPlan Company Profile
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles
- Five stocks we like better than MultiPlan
- How to Most Effectively Use the MarketBeat Earnings Screener
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
- How to Calculate Stock Profit
- Is Aggressive Trading Your Path to Quick Profits?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Williams Sonoma Stock Could Be Ripe for a Short at Current Levels
Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.